Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV001722450 | SCV000621623 | likely benign | not provided | 2020-08-04 | criteria provided, single submitter | clinical testing | |
Invitae | RCV000706187 | SCV000835224 | benign | Tuberous sclerosis 2 | 2024-01-07 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002255426 | SCV000851087 | likely benign | Hereditary cancer-predisposing syndrome | 2016-07-15 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Genome- |
RCV000706187 | SCV002039288 | benign | Tuberous sclerosis 2 | 2021-11-07 | criteria provided, single submitter | clinical testing | |
Sema4, |
RCV002255426 | SCV002533367 | likely benign | Hereditary cancer-predisposing syndrome | 2022-03-09 | criteria provided, single submitter | curation | |
Ce |
RCV001722450 | SCV004133843 | likely benign | not provided | 2023-03-01 | criteria provided, single submitter | clinical testing | TSC2: BP4, BP7 |